국내에서는 줄기세포 치료제가 약품으로 분류돼 엄격한 임상시험을 거쳐 안전성과 약효를 입증해야 허가를 받을 수 있다.
In Korea, stem cell treatments are classified as drugs, and they have to go through rigorous clinical trials to prove their safety and efficacy before being approved.